First Tracks Biotherapeutics Announces $200 Million Private Placement
Bitget2026/10/15 12:09- First Tracks Biotherapeutics agreed to sell 6,106,870 shares of common stock at $32.75 per share in a private placement.
- Expected gross proceeds total approximately $200 million before placement agent fees and other expenses.
- Closing is expected on October 19, 2026, subject to customary closing conditions.
- Proceeds will fund general corporate purposes, including clinical development of ANB033, a CD122 antagonist.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Shipping stocks fell 6.8% weekly, underperforming the market, while the tanker sector has surged 115% year-to-date.
The Capital Link Maritime Index fell by 6.8% last week, significantly underperforming the S&P 500. Despite the industry's total market capitalization shrinking by $6.5 billion, the tanker sector led the way with a 115% increase year-to-date, and trading activity surged sharply.
Strong earnings report can't stop sell-off! Credit concerns intensify as US bank stocks record longest losing streak since 2008
Although the financial reports released so far by some of the largest banks in the United States remain robust, U.S. bank stocks are currently experiencing their longest period of decline since the 2008 financial crisis.
3M (MMM.US) issues 3.16 million warrants to Amazon, expanding data center product cooperation
Shares of 3M rose after the company announced an expanded partnership with Amazon Data Center products.
Crypto prices
More
